Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Neasa HouriganSearch all speeches

Results 541-560 of 7,412 for speaker:Neasa Hourigan

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: In the context of a sector that has seen potency exponentially increase, with all the problematic impacts that would have on people, I ask all three groups whether they think the current legislation is suitable to deal with that issue. Does the current legislative approach address potency?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: I think the answer from Mr. Ryan is it does not, at all.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: -----it does not matter to the Department-----

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: If it was 1978 and you had a joint and it was one level and you get arrested in 2008 and it is eight times more potent it makes no difference to the Department.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: Okay, but the impact on the person is completely different. Does he take that point?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: What Ms McArdle means by that is if there is a new drug the HSE puts it onto the list of controlled substances and it is now something that would be recognised. I am asking how the HSE's current policies are addressing situations where is an existing drug the nature of which is changing out of all recognition.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: How does one look at the impacts without looking at the potency? For example, if all of a sudden a drug we have been familiar with for decades changes to the point where it is eliciting health outcomes that were not envisaged, how can that be addressed without considering the potency?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: However, the Department of course cannot regulate potency in any way.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: It has no control.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: Okay. Moving to the HSE, does that lack of control concern the officials?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: What Ms Queally is describing is, at the end of a process or at the end of the imbibing of a substance, we record and then respond.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: I thank Dr. Keenan. That is good to hear.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: I will address the issue of supports for people recovering from addiction, so my question is mainly to the witnesses from the HSE and Department of Health. I represent Dublin 1 and 7. Many addiction supports are available while people are in active addiction. Following on, thankfully, we have a Housing First strategy and people are found placements, often in private accommodation....

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: I will stop Mr. Doyle there. I will outline the situation as I understand it. There is the Department of Health, where the money starts. That is point A. We could go back to the Department of Public Expenditure, National Development Plan Delivery and Reform, but we will start at this point A. Point B, then, is the HSE. The HSE then works with the Department of Housing, Local Government...

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: Is the HSE tracking how many placements are in each area and if the number is appropriate?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: Yes.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: The HSE knows where people are but is not making any judgment call on whether the provision would be appropriate in a given area.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: I am aware.

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: Is my characterisation correct that the euro that starts with the Department of Health goes through all those stages before it gets to the service user?

Committee on Drugs Use: Drug Use Policy: HSE, Department of Justice and Department of Health (20 Jun 2024)

Neasa Hourigan: The HSE goes through the Department of Housing, Local Government and Heritage.

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Neasa HouriganSearch all speeches